Eris Lifesciences Limited
NSE: ERIS
About Eris Lifesciences Limited
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
Summary as recorded on Thu, 13 Aug, 2026.
Results
No scheduled results found for ERIS.
Historical quarterly results aren't available in the current data feed.
Corporate Actions
No recent corporate actions for ERIS.
Latest News · Eris Lifesciences Limited
Company overview assembled from NSE results / corporate-action feeds and market news. Not investment advice.

